✦ LIBER ✦

Phase I and pharmacokinetic study of DACA (XR5000): a novel inhibitor of topoisomerase I and II

✍ Scribed by Twelves, C J; Gardner, C; Flavin, A; Sludden, J; Dennis, I; Bono, J de; Beale, P; Vasey, P; Hutchison, C; Macham, M A

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II study of XR 5000, an inhibitor

✍ F Caponigro; C Dittrich; J.B Sorensen; J.H.M Schellens; F Duffaud; L Paz Ares; D 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 89 KB

Phase II study of XR5000 (DACA), an inhi

✍ Christian Dittrich; Veronique Dieras; Pierre Kerbrat; Cornelis Punt; Roberto Sor 📂 Article 📅 2003 🏛 Springer US 🌐 English ⚖ 65 KB

Phase II study of XR 5000 (DACA), an inh

✍ C Dittrich; B Coudert; L Paz-Ares; F Caponigro; M Salzberg; T Gamucci; X Paolett 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 108 KB

Phase I and pharmacokinetic study of the

✍ Jong, R S de; Vries, E G E de 📂 Article 📅 1999 🏛 Nature Publishing Group 🌐 English ⚖ 107 KB

Phase I and pharmacokinetic study of edo

✍ Yasuhide Yamada; Tomohide Tamura; Noboru Yamamoto; Tatsu Shimoyama; Yutaka Ueda; 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 266 KB

Population Pharmacokinetic and Dynamic A

✍ J.H.M. Schellens; B. Heinrich; M. Lehnert; M.E. Gore; S.B. Kaye; P. Dombernowsky 📂 Article 📅 2002 🏛 Springer US 🌐 English ⚖ 112 KB